logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Sarepta Pharmaceuticals Jumps on Competitor’s Failure

  +Follow August 16, 2013 9:54AM
Share:
Tickers Mentioned:

Sarepta Therapeutics Inc. (SRPT) experienced a bit of schadenfreude on Aug. 16 as a direct competitor stumbled badly at the finish line.

Competitor GlaxoSmithKline plc (GSK) had been neck-and-neck with Serepta in the race to develop a breakthrough muscle disorder drug to treat Duchenne Muscular Dystrophy. Both drugs were far ahead of the pack in the development process.

That is, until Baird analyst Brian Skorney reported that Glaxo’s drug, drisapersen, has encountered major stumbling blocks on several fronts that could significantly hamper development. Skorney cited clinical, regulatory, and commercials issues with the drug. Most importantly, the drug did not seem to effectively treat symptoms of the disease at the targeted dose.

Serepta’s drug, eteplirsen, so far has seemed to be effective at treating symptoms of Duchenne. Clinical trials have taken place in the UK. On Aug. 7 the company released promising clinical trial information, which will form the basis of their application for US FDA approval in early 2014.

Duchenne is a severely debilitating form of muscular dystrophy. The recessive muscular degenerative disorder affects approximately 1 in 3,600 boys, and life expectancy for sufferers is usually around 25. A drug from either company would be the first on the American market designed to treat the disorder.

The London-based GlaxoSmithKline , which is the fourth largest pharmaceutical company in the world, shrugged off the setback. Their stock is up .33 percent to hit $51.70 a share.

Serepta is up 6.77 percent to hit $34.21 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Signup for our daily newsletter and get our best articles emailed right to you!

Results for GSK
SportDoctorJLC
31 Jul 15 18:03:11
RT @biospace: .@Pfizer $PFE CEO on the Prowl for New Acquisitions. $GSK $ACT #pharma http://t.co/ro7goKKkL1 http://t.co/bYKiwvDOlA
Alex Mellado
31 Jul 15 16:26:12
RT @biospace: .@Pfizer $PFE CEO on the Prowl for New Acquisitions. $GSK $ACT #pharma http://t.co/ro7goKKkL1 http://t.co/bYKiwvDOlA
Michael James
31 Jul 15 16:21:53
After A MASSIVE 525% Gain On $GEQU, We Have A New Pick Ready! Special Update: http://t.co/wFGuoX67mX $LFAP $GSK $ROX
Michael Cook
31 Jul 15 16:21:47
Our Stock Alerts Gained Over 550% This Month Already! See Our Huge New Pick Coming This Week: http://t.co/abs4Q0eCx9 $LFAP $GSK $ROX
Paul Henry
31 Jul 15 16:19:12
Our Penny Stock Picks Have Gained 3,600% In 10 Months! Get Early Access To Our Next Pick: http://t.co/xXdYdpiHOc $LFAP $GSK $ROX
IH News Desk
31 Jul 15 16:03:35
$GSK Short Sales Updated Friday, July 31, 2015 6:10:56 PM $RGSE $GSK $SGYP $AKS http://t.co/ISEfdE8182
Yamasuta
31 Jul 15 16:00:06
$GSK - BUY Signal at 43.59 on Jul 30, 15 By YaMasuta, FREE Algorithmic Trading Software http://t.co/LaBa1JZUYz #stock #trading #trade
dailystockplays.com
31 Jul 15 15:42:15
Stochastic Overbought http://t.co/vuBKRnWqD3 $EVHC $NCLH $WDC $INFN $XHB $AMH $SU $CTSH $TJX $ACN $AGG $RRD $GSK $CNP $SWFT $GIS $ITB $SO
FinSentS UK100
31 Jul 15 15:18:37
$GSK:LN GlaxoSmithKline : Decision paves way for WHO to assess malaria vaccine #GLAXOSMITHKLINE PLC http://t.co/aNGLvpy1Mg #LDN100
Kristina Duering
31 Jul 15 15:05:11
RT @CashRocket: $RDUS new CMO was $GSK's Medicine Development Leader for denosumab (Prolia/Xgeva by $AMGN). Solid choice. http://t.co/d3W…
PolgarStocks
31 Jul 15 14:16:06
$LNKD Filings Updated Friday, July 31, 2015 5:07:06 PM $XOM $XOM $GDX $GSK http://t.co/EWooeCn7rQ
IH News Desk
31 Jul 15 14:03:07
$VLO Short Sales Updated Friday, July 31, 2015 4:10:55 PM $GSK $TIER $VDSI $SGYP http://t.co/cbkfujTm2d
Ross
31 Jul 15 13:41:43
RT @CashRocket: $RDUS new CMO was $GSK's Medicine Development Leader for denosumab (Prolia/Xgeva by $AMGN). Solid choice. http://t.co/d3W…
CR
31 Jul 15 13:39:47
$RDUS new CMO was $GSK's Medicine Development Leader for denosumab (Prolia/Xgeva by $AMGN). Solid choice. http://t.co/d3WJdxfOdN
Javier Blanco
31 Jul 15 13:15:40
RT @biospace: .@Pfizer $PFE CEO on the Prowl for New Acquisitions. $GSK $ACT #pharma http://t.co/ro7goKKkL1 http://t.co/bYKiwvDOlA
PolgarStocks
31 Jul 15 13:15:36
$XOM Last Price Updated Friday, July 31, 2015 4:07:05 PM $DXJ $IYT $GSK $HYG http://t.co/uiRiHc0nCs
Yamasuta
31 Jul 15 13:15:00
$GSK - BUY Signal at 43.59 on Jul 30, 15 By YaMasuta, FREE Algorithmic Trading Software http://t.co/LaBa1JZUYz #stock #trading #trade
Charles Zinnel
31 Jul 15 12:40:24
$ARIA huge upside potential and STRONG BUYOUT CANDIDATE!!!!!! $pdli $pfe $jnj $amgn $ctic $aria $onty $mrk $gsk $bayry
Charles Zinnel
31 Jul 15 12:39:53
$ARIA rallying! Huge $200m financing! $pdli $pfe $jnj $amgn $ctic $aria $onty $mrk $gsk $bayry
RDL Investments Ltd
31 Jul 15 12:18:46
RT @RatingsNetwork: GlaxoSmithKline plc upgraded by Zacks to hold. http://t.co/N83UAJTdTU $GSK #GSK
Don Seiffert
31 Jul 15 12:16:55
Parexel $PRXL to lay off 125 in North Carolina who were just laid off less than a year ago by $GSK http://t.co/GsxagAz1Rr
Peter Chu
31 Jul 15 11:46:45
2016 $ESRX drug exclusions: $GSK Levitra $PFE Xeljanz $GILD Harvoni $JNJ Olysio $VVUS Qsymia $NVO Victoza http://t.co/dKayKBnzDp
Patricia Aguilar
31 Jul 15 11:27:37
RT @biospace: .@Pfizer $PFE CEO on the Prowl for New Acquisitions. $GSK $ACT #pharma http://t.co/ro7goKKkL1 http://t.co/bYKiwvDOlA
binaryoptionsocial
31 Jul 15 10:45:31
$GSK received a new alert. Find out why at http://t.co/rRtKVALqb5 #stocks #daytrading #trading #mkt #NYSE #NASD… http://t.co/Csk7miIhta
US Consumer News
31 Jul 15 10:45:08
GlaxoSmithKline plc upgraded by Zacks to hold. http://t.co/chrPPTvQcW $GSK #GSK
Ticker Report
31 Jul 15 10:42:37
GlaxoSmithKline plc Upgraded to Hold at Zacks $GSK http://t.co/MaGmwZDfXz
Media Sentiment
31 Jul 15 10:41:55
$GSK received a new alert. Find out why at http://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt #NYSE #NASDAQ #markets 384
MarketBeatCom
31 Jul 15 10:40:47
GlaxoSmithKline plc upgraded by Zacks to hold. http://t.co/N83UAJTdTU $GSK #GSK
Dakota Financial
31 Jul 15 10:40:11
GlaxoSmithKline plc Upgraded to Hold at Zacks $GSK http://t.co/f53f5Edigl
Yamasuta
31 Jul 15 10:35:00
$GSK - BUY Signal at 43.59 on Jul 30, 15 By YaMasuta, FREE Algorithmic Trading Software http://t.co/LaBa1JZUYz #stock #trading #trade
Breaking News Now
31 Jul 15 10:20:02
$GSK: New SEC Filing for GSK: Form 6-K (No. 0001191638-15-000986): http://t.co/wkoGTBH7H4
Company SEC Filings
31 Jul 15 10:19:04
NEW SEC Filing for $GSK filed a moment ago: http://t.co/GWXualSADR http://t.co/nMY2AeLJWf
StockNews
31 Jul 15 10:19:02
$GSK - Report of Foreign Issuer (6-k) http://t.co/c5mDOyqezd
Sweet Platform
31 Jul 15 10:18:37
GSK Top news - Jul 31st, 2015 $GSK http://t.co/VgtPmaAi5E
Conf Call Tran
31 Jul 15 10:18:08
GlaxoSmithKline: Securities Exchange Act Of 1934 http://t.co/4aLSIbhB6B $GSK
PolgarStocks
31 Jul 15 10:12:33
$GSK Financials Updated Friday, July 31, 2015 1:07:08 PM $QCOM $GWPH $TCK $DUST http://t.co/tGNwdtcwg1
IH News Desk
31 Jul 15 09:58:10
$GSK Stock Message Board Updated Friday, July 31, 2015 12:11:11 PM $BLFS $UWTI $IYT $GWPH http://t.co/JWSzeJbIRX
Rosner Stocks
31 Jul 15 09:57:20
$EBAY Stock Forum Updated Friday, July 31, 2015 11:59:25 AM $GSK $XLI $DIA $MJMJ http://t.co/PsPvTxG1b9
Lupita López Lechuga
31 Jul 15 09:49:49
RT @biospace: .@Pfizer $PFE CEO on the Prowl for New Acquisitions. $GSK $ACT #pharma http://t.co/ro7goKKkL1 http://t.co/bYKiwvDOlA
Juan Sagales
31 Jul 15 09:44:41
RT @biospace: .@Pfizer $PFE CEO on the Prowl for New Acquisitions. $GSK $ACT #pharma http://t.co/ro7goKKkL1 http://t.co/bYKiwvDOlA
FunGuns09
31 Jul 15 09:26:03
RT @PolgarStocks: $GSK Investor Opinions Updated Friday, July 31, 2015 12:07:19 PM $BMY $MDY $XBI $TPAC http://t.co/HN1GUbeenP
janet gale
31 Jul 15 09:24:05
$GSK - GlaxoSmithKline PLC Adjusted Free Cash Flow Performance Measure http://t.co/cxAOfxiuvH
ADVFN
31 Jul 15 09:24:05
$GSK - GlaxoSmithKline PLC Adjusted Free Cash Flow Performance Measure http://t.co/Mg75g1tsZf
Shane Day
31 Jul 15 09:24:04
$GSK - GlaxoSmithKline PLC Adjusted Free Cash Flow Performance Measure http://t.co/Ri6dIBAY6o
FiercePharma
31 Jul 15 09:14:45
$GSK hiring 130 at inhaler facility, even as CRO axes up to 200 GSK alum http://t.co/y4E6Yv6Ehd #pharma by @EricPFierce
PolgarStocks
31 Jul 15 09:12:07
$GSK Investor Opinions Updated Friday, July 31, 2015 12:07:19 PM $BMY $MDY $XBI $TPAC http://t.co/HN1GUbeenP
BioPharma Dive
31 Jul 15 09:00:08
From $GSK to $PRXL—and now, unemployed http://t.co/Op9MWNQalr
IH News Desk
31 Jul 15 08:57:38
$GSK Filings Updated Friday, July 31, 2015 11:11:18 AM $VHT $SLTD $GWPH $DIS http://t.co/PNbzl0sZbk
Sy Mukherjee
31 Jul 15 08:38:14
From $GSK to $PRXL—and now, unemployed http://t.co/j7uVzhIPfc
Market Int Center
31 Jul 15 08:38:04
GlaxoSmithKline PLC $GSK Trading Near $44.00 Resistance Level ( http://t.co/12TIXwXO4P )
				
				
  +Follow August 16, 2013 9:54AM
Share:

Comments

 

blog comments powered by Disqus

 Today's Must Reads

Beyond Twitter: 5 Small-Cap Tech Plays Nobody’s Talking About


Will the Fed Continue Its Track Record of Unprecedented Moves?

Facebook versus Google: Who Rules the Internet?

Are These the Worst Business Documentaries on Netflix?


Saving the

Small-Cap Market

 

Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN